Battling ‘Sludge’ in Clinical Trials: A Call to Action
The concept of sludge provides an invaluable lens for clinical research professionals in identifying and mitigating unnecessary friction and bottlenecks.
Breaking the Cycle of Ineffective Site Initiation Practices
Trial leaders recognize traditional site initiation processes often lead to excessive delays but have struggled to adapt and improve.
How ‘Slow Thinking’ Enables Clinical Research Teams to Work Faster
Learn the value of slow thinking in enhancing decision-making and outcomes in clinical research and beyond.
ArcheMedX To Present at Innovation Showcase and Poster Sessions during the 2023 CNS Summit
Analyses of 95,724 clinician learners across CNS-related conditions demonstrated significant knowledge gaps and increases in clinical mastery, learn more with ArcheMedX at the CNS Summit
Leveraging Behavioral Science for Clinical Trial Success
Explore how behavioral science can revolutionize clinical trial methodologies and overcome operational challenges. Dive deep into the interplay between human behavior and clinical research with insights from Dr. Brian McGowan and the ArcheMedX team.
Top 10 Lessons from the Pioneers of Behavioral Science in Healthcare
Earlier this month I had the honor of presenting our research at the 2023 Nudges In Healthcare Symposium and I can not recommend the experience strongly enough. Dating back to 2018 University of Pennsylvania’s Nudge Unit and Center for Health Incentives & Behavioral Economics have hosted clinician researchers from around
Connect with ArcheMedX at SCOPE 2023
How can you minimize the performance risks given the complexities of a clinical trial and be ready to effectively conduct your next study?
ArcheMedX To Present New Findings & Clinical Trial Innovations At The CNS Summit
Analyses of 42,656 clinician learners across 69 CNS-related educational activities reveals clinicians may be unprepared to effectively conduct clinical trials
Charlottesville, VA (PRWeb) November 16, 2022
ArcheMedX, the leading provider of clinician readiness solutions for the life sciences and healthcare industries, today announced the Company’s expanded participation at the CNS Summit taking
ArcheMedX Releases New Oncology Findings Ahead Of ESMO Congress Revealing Clinician Readiness
2021 was a historic year in the battle to defeat cancer.
More novel cancer treatments became available than ever before with the number of Oncology specific clinical trials also reaching an all-time high, up 56% from 2016 and mostly focused on rare cancer indications.
With global spending on Oncology expected to exceed $300
Decentralized trials (DCTs) at Risk, or Ready?
It should come as little surprise that the rise in decentralized trials (DCTs) and increase in study complexities have magnified performance demands across clinical trial teams.
A recent survey by Ernst & Young found 50% of clinical trials will be hybrid or decentralized by 2024. This is welcome news for sponsors
